Deconstructing senescence phenotypes in cells of the bone and bone marrow.
Abstract
Cellular senescence in osteogenic mesenchymal cells contributes to age-related bone loss. The bone marrow hosts myeloid cells, the precursors of immune cells, as well as mesenchymal cells, which give rise to osteoblasts and osteocytes. The senotype and senolytic response of bone marrow cells, particularly hematopoietic cells, in age-related bone loss is unclear. In this issue, Doolittle et al. showed that of all immune cells, myeloid cells had the strongest senescence profile, yet the relative level of senescence remained lower than that of mesenchymal stromal cells. Mesenchymal cells displayed a profound senotype, rendering them susceptible to senolytic clearance protecting against bone loss. By contrast, selective clearance of p16+ myeloid cells was not long-lasting and, hence, did not fully protect against age-related bone loss. These findings underscore the challenges of developing senolytic strategies for tissues with mixed senotypes, such as bone.
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
The paper claims that mesenchymal stromal cells exhibit a profound senotype that makes them susceptible to senolytic clearance, which can protect against age-related bone loss. This research is relevant as it addresses cellular senescence, a root cause of aging, and explores potential therapeutic strategies to mitigate age-related bone loss, contributing to the understanding of longevity and aging mechanisms.
Author of this paper? Send a correction.